🔎 Trials Near Me

Почетна › Рак (све врсте) › Орегон › Portland

Kliničke studije za Рак (све врсте) u gradu Portland, OR

36 studija za Рак (све врсте) traži učesnike na lokacijama u gradu Portland i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.

Zvanični tekst studije (na engleskom)

Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

Post-Marketing Study for Early-Stage Low-Risk Breast Cancer Treatment Using ProSense® Cryoablation (ChoICE Trial)

Тражи се учесник
  • Legacy Medical Group-Surgical Oncology at Good Samaritan, Portland
Узраст 70 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT07629206

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

Тражи се учесникФаза 3
  • Legacy Good Samaritan Hospital and Medical Center, Portland
  • Providence Portland Medical Center, Portland
  • Providence Saint Vincent Medical Center, Portland
  • и још 2
Узраст 18 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT06580314

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Тражи се учесникФаза 3
  • Providence Portland Medical Center, Portland
  • Providence St. Vincent Medical Center, Portland
  • Kaiser Permanente Interstate Medical Office Central, Portland
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06119581

Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

Тражи се учесникФаза 2/3
  • Providence Portland Medical Center, Portland
  • Oregon Health and Science University OHSU, Portland
Сви узрасти · Оба пола · Ажурирано 2. 11. 2026. · NCT03435796

A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)

Тражи се учесникФаза 1/2
  • Oregon Health and Science University /ID# 272282, Portland
Узраст 18 и старији · Оба пола · Ажурирано 27. 10. 2026. · NCT06953960

Connect for Cancer Prevention Study (Connect)

Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
  • Kaiser Permanente Northwest, Portland
Узраст од 30 до 70 · Оба пола · Ажурирано 26. 10. 2026. · NCT04609072

Galleri® in the Medicare Population.

Тражи се учесникЗдраве особе су добродошле
  • OHSU CEDAR Clinical Trials Portland, Portland
  • OHSU CEDAR Clinical Trials Richmond, Portland
Узраст 50 и старији · Оба пола · Ажурирано 19. 10. 2026. · NCT05673018

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

Тражи се учесникФаза 2/3
  • OHSU Center for Health & Healing 1, Portland
  • Oregon Health and Science University, Portland
  • OSHU Center for Health and Healing 2, Portland
Узраст 18 и старији · Оба пола · Ажурирано 14. 10. 2026. · NCT06989437

A Study of ASP3082 in Adults With Advanced Solid Tumors

Тражи се учесникФаза 1
  • Oregon Health and Science University, Portland
Узраст 18 и старији · Оба пола · Ажурирано 14. 10. 2026. · NCT05382559

A Phase 1 Dose-escalation Study of UGN-501 Administered Intravesically in Adult Participants With Recurrent NMIBC

Тражи се учесникФаза 1
  • Oregon Health & Science University, Portland
Узраст 18 и старији · Оба пола · Ажурирано 13. 10. 2026. · NCT07725796

FOG-001 in Locally Advanced or Metastatic Solid Tumors

Тражи се учесникФаза 1/2
  • Oregon Health and Science University, Portland
Узраст 18 и старији · Оба пола · Ажурирано 7. 10. 2026. · NCT05919264

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

Тражи се учесникФаза 1/2
  • Providence Neurological Specialties West, Portland
Узраст 18 и старији · Оба пола · Ажурирано 6. 10. 2026. · NCT03328078

A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)

Тражи се учесникФаза 1/2
  • Oregon Health and Science University ( Site 3004), Portland
1 Month – 17 Years · Оба пола · Ажурирано 6. 10. 2026. · NCT06941272

A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies

Тражи се учесникФаза 2
  • Providence Portland Medical Center /ID# 277727, Portland
Узраст 18 и старији · Жене · Ажурирано 1. 10. 2026. · NCT07024784

A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma

Тражи се учесникФаза 1
  • Oregon Health & Science University, Portland
Узраст 18 и старији · Оба пола · Ажурирано 30. 9. 2026. · NCT07192471

A Study of PHN-012 in Patients With Advanced Solid Tumors

Тражи се учесникФаза 1
  • PHN-012-001 Site, Portland
Узраст 18 и старији · Оба пола · Ажурирано 29. 9. 2026. · NCT07127874

A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism

Тражи се учесникФаза 3
  • Investigative Site, Portland
Узраст 18 и старији · Оба пола · Ажурирано 28. 9. 2026. · NCT06881992

A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer

Тражи се учесникФаза 3
  • Oregon Health and Science University /ID# 280071, Portland
Узраст 18 и старији · Оба пола · Ажурирано 23. 9. 2026. · NCT07365241

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

Тражи се учесникФаза 2
  • Providence Health & Services, Portland
Узраст 12 и старији · Оба пола · Ажурирано 22. 9. 2026. · NCT02693535

A Phase 1/1b Study of IAM1363 in HER2 Cancers

Тражи се учесникФаза 1
  • Providence Cancer Institute, Portland
Узраст 18 и старији · Оба пола · Ажурирано 9. 9. 2026. · NCT06253871

A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma

Тражи се учесникФаза 1
  • Providence Portland Medical Center, Portland
Узраст 18 и старији · Оба пола · Ажурирано 28. 8. 2026. · NCT07075185

IMmunotherapy: Prospective Assessment of Cannabis Treatment in Cancer

Тражи се учесникОпсервациона студија
  • Oregon Health and Science University, Portland
Узраст 18 и старији · Оба пола · Ажурирано 26. 8. 2026. · NCT06206941

Project: Every Child for Younger Patients With Cancer

Тражи се учесникОпсервациона студија
  • Legacy Emanuel Children's Hospital, Portland
  • Oregon Health and Science University, Portland
До 25 година · Оба пола · Ажурирано 25. 8. 2026. · NCT02402244

A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer

Тражи се учесникФаза 2
  • Oregon Health and Science University, Portland
Узраст од 1 до 39 · Оба пола · Ажурирано 7. 8. 2026. · NCT05999994

Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer

Тражи се учесникФаза 2
  • OHSU Knight Cancer Institute, Portland
Узраст 18 и старији · Оба пола · Ажурирано 16. 7. 2026. · NCT05705492

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

Тражи се учесникФаза 2
  • Oregon Health and Science University, Portland
Узраст 18 и старији · Оба пола · Ажурирано 7. 7. 2026. · NCT07216443

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

Тражи се учесникФаза 1/2
  • Providence Cancer Institute Franz Clinic, Portland
Узраст 18 и старији · Оба пола · Ажурирано 7. 7. 2026. · NCT05768139

A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)

Тражи се учесникФаза 1
  • GSK Investigational Site, Portland
Узраст 18 и старији · Оба пола · Ажурирано 25. 6. 2026. · NCT06431594

Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI

Тражи се учесник
  • VA Portland Health Care System, Portland, OR, Portland
Узраст од 18 до 75 · Оба пола · Ажурирано 17. 6. 2026. · NCT05486572

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

Тражи се учесникФаза 2
  • Oregon Health & Science Institute (OHSU), Portland
Узраст 18 и старији · Оба пола · Ажурирано 6. 5. 2026. · NCT01042379

Beat Childhood Cancer Specimen Banking and Data Registry

Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
  • Randall Children's Hospital, Portland
Сви узрасти · Оба пола · Ажурирано 3. 2. 2026. · NCT04715178

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Тражи се учесникОпсервациона студија
  • Massive Bio SYNERGY-AI site, Portland
Сви узрасти · Оба пола · Ажурирано 28. 10. 2025. · NCT03452774

Observational Study of Iris Tumors

Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
  • Oregon Health & Science University, Portland
Узраст 18 и старији · Оба пола · Ажурирано 9. 9. 2025. · NCT03809585

A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies

Тражи се учесникФаза 1/2
  • Oregon Health & Science University, Portland
Узраст 18 и старији · Оба пола · Ажурирано 13. 2. 2025. · NCT05669430

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

Тражи се учесник
  • Kaiser Permanente Northwest - Oncology Clinic, Portland
Узраст 18 и старији · Оба пола · Ажурирано 27. 11. 2024. · NCT03860883

Studije za Рак (све врсте) u drugim gradovima

Ostale studije u gradu Portland

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.